fda compounding semaglutide crackdown november 2025 Ozempic Knockoffs Survive Thanks to Loophole Hims & Hers stock falls

39 If you can formulate a compounded product that genuinely spares lean mass in a way the branded vials dont, you have a defensible, legal clinical justification to stay in the game

Int J Mol Sci 2022;23:4259

Studies show 1020% body weight loss in 612 months

Read the full story here - #FDAApproval #HeartFailure #LasixOnyu #MedicalInnovation #CardiologyNews #PharmaUpdate #HealthcareTechnology #PatientCare #MedtigoNews #DrugApproval #MedicalCommunity #HealthcareInnovation #ClinicalUpdates #Furosemide #DigitalHealth #HomeTreatment #medtigo To view or add a comment, sign in #MoleculeMonday: Thalidomide was once a global tragedy

This goes a step further than the standard TSH-only screening, showing you not just the signal from the brain, but the levels of the hormones themselves

Semaglutide is often chosen first if cost is a major barrier, if insurance covers it more reliably, or if someone is nervous about potentially stronger gastrointestinal side effects, and it has a long track record in both diabetes and chronic weight management, so clinicians may start there for a conservative yet effective approach, especially for modest weight loss goals, then consider switching to tirzepatide later if results plateau, side effects remain manageable, and coverage improves, and some practices even map out this stepwise plan during the very first visit